Literature DB >> 6391226

Epidemic Shiga bacillus dysentery in Central Africa.

J R Ebright, E C Moore, W R Sanborn, D Schaberg, J Kyle, K Ishida.   

Abstract

An outbreak of dysentery began late in 1979 in Central Africa and spread to involve a major portion of Zaire as well as Rwanda and Burundi. We traveled to a mission hospital in northeast Zaire during the epidemic and isolated Shigella dysenteriae, type 1, from most of the patients studied. All isolates were resistant to ampicillin, tetracycline, chloramphenicol, sulfathiazole, and streptomycin but sensitive to trimethoprim-sulfamethoxazole. Antimicrobial resistance was transferable to Escherichia coli, and at least three plasmids were identified in the donor Shigella isolates by using agarose gel electrophoresis. One was coded for ampicillin, tetracycline, and chloramphenicol resistance while a second conferred resistance to ampicillin and chloramphenicol but not tetracycline. A third large plasmid of approximately 120 megadaltons could not be transferred to E. coli recipients. All S. dysenteriae isolates yielded identical kinetic growth curves when analyzed on the Abbot MS-2 Research System. This is the most extensive outbreak of dysentery caused by S. dysenteriae reported since the Central American epidemic of 1969, and the first epidemic caused by a strain resistant to ampicillin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6391226     DOI: 10.4269/ajtmh.1984.33.1192

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

Review 1.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

2.  Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi.

Authors:  D Engels; T Madaras; S Nyandwi; J Murray
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

3.  The potential of diagnostics for improving community health in less developed countries.

Authors:  P J Imperato
Journal:  J Community Health       Date:  1985

4.  Shigella: A Highly Virulent and Elusive Pathogen.

Authors:  Mussaret Bano Zaidi; Teresa Estrada-García
Journal:  Curr Trop Med Rep       Date:  2014-06-01

5.  A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1.

Authors:  Kwang-Il Jeong; Quanshun Zhang; John Nunnari; Saul Tzipori
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.

Authors:  F Rogerie; D Ott; J Vandepitte; L Verbist; P Lemmens; I Habiyaremye
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

8.  Molecular epidemiology of plasmid patterns in Shigella flexneri types 1-6.

Authors:  A Gebre-Yohannes; B S Drasar
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

Review 9.  Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005.

Authors:  P K Ram; J A Crump; S K Gupta; M A Miller; E D Mintz
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

Review 10.  Using European travellers as an early alert to detect emerging pathogens in countries with limited laboratory resources.

Authors:  Philippe J Guerin; Rebecca Freeman Grais; John Arne Rottingen; Alain Jacques Valleron
Journal:  BMC Public Health       Date:  2007-01-19       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.